← Open Payments lookup

ALLYSON FEIST: Open Payments

NPI 1376192138 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,617 in 233 payments from 15 companies in 2025. Trend: 2023 $3,687 · 2024 $3,590 · 2025 $3,617

Food & beverage: $3,617
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.25$491
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$403
Otsuka America Pharmaceutical, Inc.52$347
Axsome Therapeutics, Inc.17$316
Teva Pharmaceuticals USA, Inc.13$293
E.R. Squibb & Sons, L.L.C.19$286
ABBVIE INC.27$275
Janssen Pharmaceuticals, Inc13$268
Vanda Pharmaceuticals Inc.15$210
Noven Therapeutics, LLC11$203

Products named: INGREZZA, REXULTI, CAPLYTA, COBENFY, VRAYLAR, Auvelity, SPRAVATO, FANAPT.

Industry payments across TX — which companies pay providers there.